Healthcare / Life Sciences

Legal advice in the healthcare / life sciences sector requires sector-specific expertise and an interdisciplinary set-up. We have both, and we advise our clients on all aspects: from legal protection and financing of a business proposition to development, production and distribution and strategic transactions

  • Mergers & acquisitions, corporate finance, IPOs / capital markets transactions (SIX, NASDAQ, NYSE, Euronext, LSE)
  • Collaboration and distribution arrangements
  • Regulatory advice and product safety
  • Exploitation and enforcement of intellectual property rights and other proprietary rights
  • Regulatory proceedings and litigation
  • Biotech and Medtech
  • Tax
  • Digitization and e-health
  • Mergers & acquisitions, corporate finance, IPOs / capital markets transactions (SIX, NASDAQ, NYSE, Euronext, LSE)

    Our experience enables us to address the specific needs of healthcare / life sciences companies and investors in financing, M&A transactions, and IPOs / capital markets transactions. Our core experience includes:

    • Corporate set up, including employment and incentive plans
    • Financing of start-ups in all phases
    • Spin-offs from universities
    • Public and private Mergers & Acquisitions
    • Joint ventures and co-operations
    • IPOs and other capital market transactions (years of experience with IPOs of Swiss companies on SIX, NASDAQ, NYSE, Euronext, LSE)
  • Collaboration and distribution arrangements

    We advise our clients on all forms of collaborations with other market participants in the healthcare sector and on the design of distribution systems.  Our core capabilities include:

    • Research and development agreements
    • Production and specialization agreements
    • Co-marketing and co-promotion agreements
    • In-licensing and out-licensing of intellectual property rights
    • Design and implementation of distribution systems including e-commerce and online platforms
  • Regulatory advice and product safety

    We cover all areas of regulatory advice in the healthcare sector and advise our clients in particular in the following areas:

    • Marketing authorizations for pharmaceutical products and other authorizations under public law
    • Pricing and reimbursement claims for therapeutic products
    • Data exclusivity and advertising of therapeutic products
    • Competition law
    • Regulated activities such as clinical trials, human research or genetic research
    • Product regulation including product safety and product recalls
  • Exploitation and enforcement of intellectual property rights and other proprietary rights

    Intangible assets are a core resource in the healthcare sector.  We assist our clients in protecting, exploiting and enforcing their rights to intellectual property in the biotechnology, medical device and pharmaceutical sectors, including e-health and data based development.  Our core competencies include:

    • Advice on IP strategies to protect business models
    • Advice on group IP strategies (including tax)
    • Licensing transactions
    • Representation before courts and authorities in disputes involving intellectual property rights, including patent litigation
    • In-licensing and out-licensing of intellectual property rights
  • Regulatory proceedings and litigation

    We advise clients in regulatory proceedings and sector-specific disputes, including patent litigation, before government agencies, courts and arbitral tribunals. Our core competencies include:

    • Representation in proceedings related to patents, trademarks, copyrights, competition, therapeutic products and other public law matters before authorities and courts
    • Representation in civil and criminal proceedings before authorities and courts
    • Representation in arbitration proceedings under institutional arbitration rules or in ad hoc proceedings
  • Biotech and Medtech

    We advise our clients in all legal and tax matters of biotech and medtech companies. Our core activities include:

    • Company set-up, employment law, incentive plans, financing and transactions
    • Advice on the development, manufacture and approval of biological and pharmaceutical products and medical devices (including equivalence with EU law)
    • Advice on marketing, pricing, discounting, labeling and promotion of medical devices
    • Advice on product safety and product liability for medical devices
    • Advice in connection with biotechnological inventions
    • Advice in connection with the Human Research Act
  • Tax

    We specialize in the tax-optimized structuring of :

    • Research and development activities (R&D deduction)
    • Capitalization of intangible property rights and their amortization
    • International licensing, royalties and other income from intellectual property rights (patent box, reduction of withholding taxes)
    • Financing rounds, venture capital and private equity investments
    • Founder and employee shareholdings and incentive plans
    • IPOs, exits (M&A), joint ventures
  • Digitization and e-health

    Electronic data are omnipresent and the requirements for their protection are continuously increasing. This is especially true when health data is are involved. Our core competencies include:

    • Data protection-compliant implementation of e-health projects, such as remote diagnostics, digital patient records and healthcare platforms
    • Advice on digitization projects in the healthcare sector
    • Legally compliant use of cloud solutions
    • Cross-border cooperation upon the use of health data
    • Preparation of documentation required to ensure data protection compliance
  • News

Homburger receives LMG Life Sciences EMEA Award «Switzerland Firm of the Year»

News
news

The Legal 500 ranks Homburger Tier 1 in 14 categories and selected 6 partners for the Hall of Fame

News

Homburger advised VectivBio on up to USD 75 m loan facility with Kreos Capital

Deals & Cases